分子血检能诊断缺血性脑卒中
|
By Xu Peng, Chief Editor 许鹏 副主编 Posted on 26 Oct 2017 |
|
图片：科研人员已发现血液中的某些生物标记物有望作为一项新检验方法的靶体，诊断最近的缺血性脑卒中（图片MNT).
缺血性脑卒中是最常见、最致命的脑卒中，起因是大动脉内的斑块内容破裂迸出，形成凝血块，阻断流向脑的血流。
迅速确定患者是否有脑卒中至关重要，因为必须在几小时内施行治疗，击碎凝血块，以逆转损害，提高完全恢复的几率。目前没有一种血检方法能诊断脑卒中或识别哪些心血管疾病患者马上发生脑卒中的风险最高。
美国路易斯安那州新奥尔良市Ochsner医疗中心的科学家及其同行比较了血液中非编码核糖核酸(RNA)的水平，这些分子调控五日内发生脑卒中的患者的基因表达，五天多以前，他们中有些人有过脑卒中，有些人没有。科学家测量了接受颈动脉内膜切除术的24名无症状患者和17名急性症状患者（前五日内急性缺血性脑血管事件）血清中微RNAs、miR-221、miR-222、miR-145和环状RNA (circR)-284的水平。
研究人员发现，急性患者血清中的miR-221水平远远低于无症状患者，而circR-284水平高于无症状患者。急性患者血清circR-284: miR-221的比值显著升高，表现出作为指示颈动脉斑块破裂和脑卒中的生物标记物的有利特性。一项确证研究招募了112名患者（47名无症状患者，41名急性患者，24名颈动脉内膜切除术后5天到180天之间发生脑血管事件的患者），证实只有急性组的血清circR-284:miR-221比升高，且灵敏度和特异性足以检测斑块破裂和脑卒中。
该研究的论文发表于2017年8月4日的《血液循环：心血管遗传学》(Circulation: Cardiovascular Genetics)杂志。作者总结说，血清circR-284: miR-221比有望成为诊断斑块破裂和脑卒中的生物标记物。此外，他们还演示了用功能相关的循环非编码RNA对作为心血管疾病的生物标记物。领衔作者、外科助理教授Hernan A. Bazan大夫说：“这项工作代表着朝理解与预测颈动脉相关脑卒中迈出的重要一步。我们正通过像这样的转化研究开发更好的疗法，并致力于预防这些疾病的发作。”
Related Links:
Ochsner医疗中心
迅速确定患者是否有脑卒中至关重要，因为必须在几小时内施行治疗，击碎凝血块，以逆转损害，提高完全恢复的几率。目前没有一种血检方法能诊断脑卒中或识别哪些心血管疾病患者马上发生脑卒中的风险最高。
美国路易斯安那州新奥尔良市Ochsner医疗中心的科学家及其同行比较了血液中非编码核糖核酸(RNA)的水平，这些分子调控五日内发生脑卒中的患者的基因表达，五天多以前，他们中有些人有过脑卒中，有些人没有。科学家测量了接受颈动脉内膜切除术的24名无症状患者和17名急性症状患者（前五日内急性缺血性脑血管事件）血清中微RNAs、miR-221、miR-222、miR-145和环状RNA (circR)-284的水平。
研究人员发现，急性患者血清中的miR-221水平远远低于无症状患者，而circR-284水平高于无症状患者。急性患者血清circR-284: miR-221的比值显著升高，表现出作为指示颈动脉斑块破裂和脑卒中的生物标记物的有利特性。一项确证研究招募了112名患者（47名无症状患者，41名急性患者，24名颈动脉内膜切除术后5天到180天之间发生脑血管事件的患者），证实只有急性组的血清circR-284:miR-221比升高，且灵敏度和特异性足以检测斑块破裂和脑卒中。
该研究的论文发表于2017年8月4日的《血液循环：心血管遗传学》(Circulation: Cardiovascular Genetics)杂志。作者总结说，血清circR-284: miR-221比有望成为诊断斑块破裂和脑卒中的生物标记物。此外，他们还演示了用功能相关的循环非编码RNA对作为心血管疾病的生物标记物。领衔作者、外科助理教授Hernan A. Bazan大夫说：“这项工作代表着朝理解与预测颈动脉相关脑卒中迈出的重要一步。我们正通过像这样的转化研究开发更好的疗法，并致力于预防这些疾病的发作。”
Related Links:
Ochsner医疗中心
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
ESR Analyzer
TEST1 2.0
Automatic Hematology Analyzer
DH-800 Series
Latest 分子诊断 News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Technology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more